Top compounds associated with response to RSPH9


Feature Type Standardized
Nominal ANOVA
mRNA ML006 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.032 0.4
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA rigosertib CTRPv2 pan-cancer AAC -0.027 0.4
mRNA AS601245 GDSC1000 pan-cancer AAC -0.028 0.4
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.4
mRNA Erlotinib CCLE pan-cancer AAC -0.038 0.4
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.031 0.4
mRNA Sorafenib CCLE pan-cancer AAC 0.039 0.4
mRNA OSI-027 GDSC1000 pan-cancer AAC -0.025 0.4
Download CSV